Authors/Disclosures
|
Julia Waskoenig, MD
|
No disclosure on file |
|
Ashutosh Mahapatra, MD
(Washington Univeristy School of Medicine, Department of Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Ethan G. Brown, MD
(University of California, San Francisco)
|
Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH. |
|
Fadar O. Otite, MD
(SUNY Upstate Medical University)
|
Dr. Otite has nothing to disclose. |
|
Burkhard Becher, PhD
|
No disclosure on file |
|
Nirav Bhatt, MD
(University of Pittsburgh)
|
Dr. Bhatt has nothing to disclose. |
|
Adriano Fontana
(Clinical Immunology, University Hospital)
|
No disclosure on file |
|
Priyank Khandelwal, MD
|
Dr. Khandelwal has nothing to disclose. |
|
Norbert Goebels, MD
(Heinrich-Heine-University)
|
Dr. Goebels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Goebels has received research support from Sanofi-Genzyme. |
|
Amer Malik, MD
(University of Miami Miller School of Medicine)
|
Dr. Malik has nothing to disclose. |
|
Debra Babcock, MD, PhD
|
No disclosure on file |
|
Seemant Chaturvedi, MD, FAHA, FÂé¶¹´«Ã½Ó³»
(University of Maryland)
|
Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS. |
|
Ralph L. Sacco, MD, MS, FAHA
|
Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care. |
|
Jose G. Romano, MD, FÂé¶¹´«Ã½Ó³»
(University of Miami, Miller School of Medicine)
|
Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI. |